Basepoint Wealth’s Amgen AMGN Stock Holding History

Basepoint Wealth’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$95.2K	Buy	271 +3	+1%	+$1.07K	0.05%	149
2025 Q4	$88K	Buy	+268	New	+$85K	0.05%	153

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Basepoint Wealth's AMGN Position: Q1 2026 in Review

Basepoint Wealth increased its Amgen (AMGN) stake by 1.1% in Q1 2026, buying an estimated $1.07K and bringing the position to 271 shares worth $95.2K. The position accounts for 0.05% of the portfolio, ranked #149.

Basepoint Wealth first reported a position in AMGN in Q4 2025 and has held it in 2 quarters since. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Basepoint Wealth held 271 shares of Amgen worth $95.2K as of Q1 2026.
Basepoint Wealth bought 3 Amgen shares in Q1 2026, an estimated $1.07K.
Amgen made up 0.05% of Basepoint Wealth's portfolio in Q1 2026, its #149 holding.
Basepoint Wealth first reported a position in Amgen in Q4 2025 and has held it in 2 quarters since.
3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Basepoint Wealth's 13F filing for Q1 2026, filed 7 May 2026.